Trial Profile
A Multicenter, Open-Label, Long-Term Study to Evaluate the Safety and Efficacy of OVF in Patients With Cancer and Breakthrough Pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 31 May 2016 New trial record